Ion Beam Applications SA IBA ( (GB:0GZK) ) has provided an update.
IBA has signed a contract with Jabil for the installation of a Be-Wide X-ray solution in Byhalia, Mississippi, to enhance Jabil’s sterilization capabilities. This collaboration will enable Jabil to expand its sterilization services for medical devices, ensuring efficiency, reliability, and scalability. The new sterilization center is expected to be operational by the end of 2027, marking a significant step for Jabil in meeting the growing demands of the medical device industry.
More about Ion Beam Applications SA IBA
IBA (Ion Beam Applications S.A.) is a global leader in particle acceleration technology, specializing in proton therapy, industrial sterilization, radiopharmacy, and dosimetry. Based in Louvain-la-Neuve, Belgium, IBA employs around 2000 people worldwide and is a certified B Corporation, meeting high standards of social and environmental performance. The company is listed on the EURONEXT stock exchange.
YTD Price Performance: 7.80%
Average Trading Volume: 885
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €427.7M
For an in-depth examination of 0GZK stock, go to TipRanks’ Stock Analysis page.